Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015, and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, 20190424-35 dated April 24, 2019, and 20200528-32 dated 28 May 2020, 20201102-43 dated Nov 02, 2020, and 20210825-62 dated Aug 25,2021 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All Market Participants are hereby informed that AUROBINDO PHARMA LIMITED (“The Company”) Offer to Buyback of upto 51,36,986 (Fifty-One Lakh Thirty Six Thousand Nine Hundred and Eighty Six Only) fully paid-up equity shares of face value of Re.1/- (Rupees One Only) each of the Company ("Equity Shares" or “shares”), at a price of Rs. 1,460/- (Rupees One Thousand Four Hundred and Sixty Only) per equity share payable in cash for an aggregate amount up to Rs.750,00,00,000/- (Rupees Seven Hundred and Fifty Crore Only) excluding transaction costs representing 0.88% of the total number of equity shares in the paid-up share capital of the company, from the equity shareholders / beneficial owners of equity shares of the company as on Tuesday, July 30, 2024 (“record date”) on a proportionate basis, through the “tender offer” route. MONDAY, AUGUST 05, 2024, to FRIDAY, AUGUST 09, 2024.
Letter of Offer is herewith attached for perusal.
Market participants are further requested to note that this offer will be as per the SEBI circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017, 20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020 and the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Mangesh Tayde
Deputy General Manager
Listing Business Relationship
August 01, 2024 |